A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience

The Metastatic Renal Cell Carcinoma Registry provides prospective data on real-world treatment patterns and outcomes in patients with metastatic renal cell carcinoma (mRCC). A total of 376 patients with mRCC and no prior systemic therapy were included in this study. This report describes initial rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Costello, Brian A., Bhavsar, Nrupen A., Zakharia, Yousef, Pal, Sumanta K., Vaishampayan, Ulka, Jim, Heather, Fishman, Mayer N., Molina, Ana M., Kyriakopoulos, Christos E., Tsao, Che-Kai, Appleman, Leonard J., Gartrell, Benjamin A., Hussain, Arif, Stadler, Walter M., Agarwal, Neeraj, Pachynski, Russell K., Hutson, Thomas E., Hammers, Hans J., Ryan, Christopher W., Mardekian, Jack, Borham, Azah, George, Daniel J., Harrison, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186183/
https://www.ncbi.nlm.nih.gov/pubmed/34364796
http://dx.doi.org/10.1016/j.clgc.2021.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186183/
https://www.ncbi.nlm.nih.gov/pubmed/34364796
http://dx.doi.org/10.1016/j.clgc.2021.07.002

Ejemplares similares